Telix Pharmaceuticals Limited
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $14.3M | $8.0M | $6.3M | $5.8M |
| FY2024 | $27.5M | $18.4M | $9.1M | $12.9M |
| FY2025 | $-17.3M | $-43.0M | $25.7M | $19.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $14.3M | $8.0M | $6.3M | $5.8M |
| FY2024 | $27.5M | $18.4M | $9.1M | $12.9M |
| FY2025 | $-17.3M | $-43.0M | $25.7M | $19.1M |